EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY-NC-ND 4.0

Increased Risk of New-Onset Asthma After COVID-19: A Nationwide Population-Based Cohort Study

Bo-Guen Kim, Hyun Lee, Sang Woo Yeom, Cho Yun Jeong, Dong Won Park, Tai Sun Park, Ji-Yong Moon, Tae-Hyung Kim, Jang Won Sohn, Ho Joo Yoon, Jong Seung Kim, Sang-Heon Kim

The Journal of Allergy and Clinical Immunology: In Practice · 2024-01 · 12 (1) · 120-132.e5

DOI: 10.1016/j.jaip.2023.09.015 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift The Journal of Allergy and Clinical Immunology: In Practice, 2024-01. Verfasst von Bo-Guen Kim und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Hanyang University College of Medicine, Seoul, Korea. Hauptthemen laut MEDLINE: COVID-19, Asthma. Die Arbeit wurde bisher 71-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Ministry of Health and Welfare, Korea National Institute of Health, Korea Health Industry Development Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Previous studies have suggested that respiratory virus infections may be associated with new-onset asthma. However, whether coronavirus disease 2019 (COVID-19) is associated with an increased risk of new-onset asthma remains unclear. OBJECTIVE: We aimed to evaluate whether recent COVID-19 increases the risk of new-onset asthma and whether COVID-19 vaccination could mitigate this risk. METHODS: We constructed 3 different study designs using the Korean National Health Insurance claim-based database: study 1: COVID-19-diagnosed subjects (COVID-19 cohort) and their matched controls; study 2: COVID-19-vaccinated subjects (vaccination cohort) and their matched controls; and study 3: vaccination cohort and their matched controls, excluding subjects diagnosed with COVID-19. RESULTS: In study 1, 1.6% of the COVID-19 cohort and 0.7% of the matched cohort developed new-onset asthma, with incidences of 31.28 and 14.55 per 1,000 person-years, respectively (P < .001). The COVID-19 cohort had a higher risk of new-onset asthma (adjusted hazard ratio [aHR] 2.14; 95% CI 1.88-2.45) than matched controls. In study 2, the vaccination cohort had a lower risk of new-onset asthma than the matched controls (aHR 0.82; 95% CI 0.76-0.89). However, among subjects without a COVID-19 diagnosis, COVID-19 vaccination was not associated with a reduced risk of new-onset asthma in study 3 (aHR 0.95; 95% CI 0.87-1.04). In subgroup analysis, the risk of new-onset asthma was significantly lower in fully vaccinated subjects and higher in older subjects and in those with diabetes mellitus than in their counterparts. CONCLUSIONS: The COVID-19 was associated with a higher incidence of new-onset asthma, which might be preventable by COVID-19 vaccination.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19AsthmaHumansAgedCohort StudiesCOVID-19 TestingCOVID-19 Vaccines

Stichwörter der Autor:innen

AsthmaCOVID-19Vaccination

Substanzen

COVID-19 Vaccines

Autor:innen und Institutionen

  • Department of Internal Medicine, Hanyang University College of Medicine, Seoul, Korea.
  • Department of Medical Informatics, Jeonbuk National University Medical School, Jeonju, Korea.
  • Department of Medical Informatics, Jeonbuk National University Medical School, Jeonju, Korea; Research Institute of Clinical Medicine of Jeonbuk National University-Biomedical Research Institute of Jeonbuk National Univ…
  • Department of Internal Medicine, Hanyang University College of Medicine, Seoul, Korea. Electronic address: sangheonkim@hanyang.ac.kr.

Förderung

  • Ministry of Health and Welfare
  • Korea National Institute of Health
  • Korea Health Industry Development Institute
  • Jeju National University Hospital
  • Texas Biomedical Research Institute

Zitieren

APA

Kim, B. G., Lee, H., Yeom, S. W., Jeong, C. Y., Park, D. W., Park, T. S., Moon, J. Y., Kim, T. H., Sohn, J. W., Yoon, H. J., Kim, J. S., & Kim, S. H. (2024). Increased Risk of New-Onset Asthma After COVID-19: A Nationwide Population-Based Cohort Study. The Journal of Allergy and Clinical Immunology: In Practice, 12(1), 120-132.e5. https://doi.org/10.1016/j.jaip.2023.09.015

Vancouver

Kim BG, Lee H, Yeom SW, Jeong CY, Park DW, Park TS, et al. Increased Risk of New-Onset Asthma After COVID-19: A Nationwide Population-Based Cohort Study. The Journal of Allergy and Clinical Immunology: In Practice. 2024;12(1):120-132.e5. doi:10.1016/j.jaip.2023.09.015

BibTeX
@article{Kim2024,
  author = {Kim, Bo-Guen and Lee, Hyun and Yeom, Sang Woo and Jeong, Cho Yun and Park, Dong Won and Park, Tai Sun and Moon, Ji-Yong and Kim, Tae-Hyung and Sohn, Jang Won and Yoon, Ho Joo and Kim, Jong Seung and Kim, Sang-Heon},
  title = {Increased Risk of New-Onset Asthma After COVID-19: A Nationwide Population-Based Cohort Study},
  journal = {The Journal of Allergy and Clinical Immunology: In Practice},
  year = {2024},
  volume = {12},
  number = {1},
  pages = {120--132.e5},
  doi = {10.1016/j.jaip.2023.09.015}
}
Kostenlos starten →